Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 59,951 | 60,242 | 41,122 | 40,676 | 32,018 |
| Operating Income | -59,951 | -60,242 | -41,122 | -40,676 | -32,018 |
| Other Income | 4,576 | 4,083 | 3,789 | 4,386 | 4,682 |
| Pre-tax Income | -55,375 | -56,159 | -37,333 | -36,290 | -27,336 |
| Income Tax | 61 | 52 | 53 | 40 | 52 |
| Net Income Continuous | -55,436 | -56,211 | -37,386 | -36,330 | -27,388 |
| Net Income | $-55,436 | $-56,211 | $-37,386 | $-36,330 | $-27,388 |
| EPS Basic Total Ops | -0.82 | -0.93 | -0.67 | -0.67 | -0.50 |
| EPS Basic Continuous Ops | -0.82 | -0.93 | -0.68 | -0.67 | -0.50 |
| EPS Diluted Total Ops | -0.82 | -0.93 | -0.67 | -0.67 | -0.50 |
| EPS Diluted Continuous Ops | -0.82 | -0.93 | -0.68 | -0.67 | -0.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.93 | -0.68 | -0.67 | -0.50 |
| EBITDA(a) | $-59,670 | $-59,860 | $-40,810 | $-40,620 | $-31,999 |